These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34155913)

  • 1. Safety and effectiveness of Phoenix atherectomy for endovascular treatment in calcified common femoral artery lesions.
    Kronlage M; Erbel C; Lichtenberg M; Heinrich U; Katus HA; Frey N; Giusca S; Korosoglou G
    Vasa; 2021 Sep; 50(5):378-386. PubMed ID: 34155913
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, effectiveness and mid-term follow-up in 136 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy.
    Giusca S; Lichtenberg M; Schueler M; Heinrich U; Eisenbach C; Andrassy M; Korosoglou G
    Heart Vessels; 2021 Mar; 36(3):366-375. PubMed ID: 32914347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Year Outcomes of Endovascular Interventions of the Common Femoral Artery: A Retrospective Analysis From Two Medical Centers.
    Shammas NW; Shammas GA; Karia R; Khalafallah R; Jones-Miller S; Shammas AN
    Cardiovasc Revasc Med; 2021 Mar; 24():72-76. PubMed ID: 32921595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shockwave™ Lithoplasty in Combination With Atherectomy in Treating Severe Calcified Femoropopliteal and Iliac Artery Disease: A Single-Center Experience.
    Radaideh Q; Shammas NW; Shammas WJ; Shammas GA
    Cardiovasc Revasc Med; 2021 Jan; 22():66-70. PubMed ID: 32563711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions.
    Yiğit G
    Vascular; 2022 Aug; 30(4):739-748. PubMed ID: 34180304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute procedural outcomes of orbital atherectomy for the treatment of common femoral artery disease: Sub-analysis of the CONFIRM Registries.
    Lee MS; Heikali D; Mustapha J; Adams G; Mahmud E
    Vasc Med; 2017 Aug; 22(4):301-306. PubMed ID: 28548625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year outcome of directional atherectomy and drug coated balloon for the treatment of common femoral artery steno-occlusive lesions.
    Cioppa A; Franzese M; Gerardi D; Pucciarelli A; Popusoi G; Stabile E; Salemme L; Sada L; Verdoliva S; Burattini O; Fimiani L; Ferrone M; Di Gioia G; Leone A; Esposito G; Tesorio T
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1310-1316. PubMed ID: 34779119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phoenix atherectomy for patients with peripheral artery disease.
    Giusca S; Hagstotz S; Lichtenberg M; Heinrich U; Eisenbach C; Andrassy M; Korosoglou G
    EuroIntervention; 2022 Aug; 18(5):e432-e442. PubMed ID: 35389346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular treatment of calcific lesions of the common femoral artery using atherectomy device associated with scoring balloon angioplasty in diabetic patients with high "major amputation" risk.
    Morosetti D; Chiocchi M; Argirò R; Salimei F; Nezzo M; Vidali S; Gasparrini F; Meloni M; Uccioli L; Gandini R
    Vascular; 2022 Jun; 30(3):463-473. PubMed ID: 34056973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single-Center Experience With Phoenix Atherectomy System in Patients With Moderate to Heavily Calcified Femoropopliteal Lesions.
    Gandini R; Pratesi G; Merolla S; Scaggiante J; Chegai F
    Cardiovasc Revasc Med; 2020 May; 21(5):676-681. PubMed ID: 31488361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [No Abstract]   [Full Text] [Related]  

  • 16. Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions (PHOTOPAC).
    Böhme T; Noory E; Beschorner U; Lerke F; Schmidt A; Scheinert D; Ito W; Zeller T; Rastan A
    Vasa; 2021 Sep; 50(5):387-393. PubMed ID: 34107772
    [No Abstract]   [Full Text] [Related]  

  • 17. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital Atherectomy Prior to Drug-Coated Balloon Angioplasty in Calcified Infrapopliteal Lesions: A Randomized, Multicenter Pilot Study.
    Zeller T; Giannopoulos S; Brodmann M; Werner M; Andrassy M; Schmidt A; Blessing E; Tepe G; Armstrong EJ
    J Endovasc Ther; 2022 Dec; 29(6):874-884. PubMed ID: 35086385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Safety and Efficacy of Rotational Atherectomy in Japanese Patients with Peripheral Arterial Disease Presenting Femoropopliteal Lesions: The J-SUPREME and J-SUPREME II Trials.
    Iida O; Urasawa K; Shibata Y; Yamamoto Y; Ando H; Fujihara M; Nakama T; Miyashita Y; Mori S; Diaz-Cartelle J; Soga Y
    J Endovasc Ther; 2022 Apr; 29(2):240-247. PubMed ID: 34510954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.